Probiotic-based therapy for Hepatocellular carcinoma: Probiotic Lactobacillus Rhamnosus attenuates phosphoenolpyruvate carboxykinase (PEPCK1) sumoylation, stabilizes PEPCK1 levels, promotes gluconeogenesis, inhibits glycolysis and attenuates the progression of hepatocellular carcinoma via upregulation of its target gene, 14/December/2018, 12.36 pm